Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sesame Care vs TD Tele-Doc Weight Loss

Two GLP-1 desks, one scoreboard. We put Sesame Care and TD Tele-Doc Weight Loss head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 4 · Grade B+

Sesame Care

Visit Sesame Care Full brief →
vs
No. 298 · Grade C

TD Tele-Doc Weight Loss

Visit TD Tele-Doc Weight Loss Full brief →

The verdict

Sesame Care takes this head-to-head.

Sesame Care scores 87 to 62 on our six-factor Brief Score — An established national telehealth marketplace with the widest real brand-name GLP-1 access on the board — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

That doesn't make TD Tele-Doc Weight Loss a bad call — it's best for readers who want brand or compounded glp-1 in va & md; weekly virtual visits + remote patient monitoring; insurance in-network. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
84
40
Supply Reliability
92
78
Transparency
94
63
Access Breadth
84
42
Clinical Oversight
80
88
Track Record
92
75
Sesame CareBrief Score 87 · 62TD Tele-Doc Weight Loss

Price, coverage & the tracker

Sesame CareTD Tele-Doc Weight Loss
Brief Score87/100 (B+)62/100 (C)
SemaglutideFrom $149/mo (brand Wegovy pill)Not disclosed
TirzepatideBrand Zepbound (price varies)Not disclosed
CoverageNationwide marketplace2 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

Sesame Care: Marketplace pricing is set per provider rather than one desk rate; the brand-name Wegovy pill line held its ~$149 entry this cycle.

TD Tele-Doc Weight Loss: New to the tracker on 1 August 2026. This program publishes no monthly medication price, so there is no line for us to track until it does.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.